80 related articles for article (PubMed ID: 25128420)
1. Darpp-32 and t-Darpp are differentially expressed in normal and malignant mouse mammary tissue.
Christenson JL; Kane SE
Mol Cancer; 2014 Aug; 13():192. PubMed ID: 25128420
[TBL] [Abstract][Full Text] [Related]
2. Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells.
Zhu S; Soutto M; Chen Z; Blanca Piazuelo M; Kay Washington M; Belkhiri A; Zaika A; Peng D; El-Rifai W
Oncogene; 2019 Jul; 38(29):5805-5816. PubMed ID: 31235784
[TBL] [Abstract][Full Text] [Related]
3. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
Rowson-Hodel AR; Wald JH; Hatakeyama J; O'Neal WK; Stonebraker JR; VanderVorst K; Saldana MJ; Borowsky AD; Sweeney C; Carraway KL
Oncogene; 2018 Jan; 37(2):197-207. PubMed ID: 28892049
[TBL] [Abstract][Full Text] [Related]
4. A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.
Castillo-Lluva S; Hontecillas-Prieto L; Blanco-Gómez A; Del Mar Sáez-Freire M; García-Cenador B; García-Criado J; Pérez-Andrés M; Orfao A; Cañamero M; Mao JH; Gridley T; Castellanos-Martín A; Pérez-Losada J
Oncogene; 2015 Sep; 34(36):4777-90. PubMed ID: 26096931
[TBL] [Abstract][Full Text] [Related]
5. Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis.
Chen Z; Zhu S; Hong J; Soutto M; Peng D; Belkhiri A; Xu Z; El-Rifai W
Gut; 2016 Jun; 65(6):925-34. PubMed ID: 25779598
[TBL] [Abstract][Full Text] [Related]
6. s-SHIP Promoter Expression Identifies Mouse Mammary Cancer Stem Cells.
Tian L; Truong MJ; Lagadec C; Adriaenssens E; Bouchaert E; Bauderlique-Le Roy H; Figeac M; Le Bourhis X; Bourette RP
Stem Cell Reports; 2019 Jul; 13(1):10-20. PubMed ID: 31204299
[TBL] [Abstract][Full Text] [Related]
7. In vivo MRI of early stage mammary cancers and the normal mouse mammary gland.
Jansen SA; Conzen SD; Fan X; Markiewicz E; Krausz T; Newstead GM; Karczmar GS
NMR Biomed; 2011 Aug; 24(7):880-7. PubMed ID: 21264977
[TBL] [Abstract][Full Text] [Related]
8. Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways.
Saidy B; Vasan R; Durant R; Greener MR; Immanuel A; Green AR; Rakha E; Ellis I; Ball G; Martin SG; Storr SJ
Sci Rep; 2023 Nov; 13(1):21163. PubMed ID: 38036593
[TBL] [Abstract][Full Text] [Related]
9. miR155 deficiency reduces breast tumor burden in the MMTV-PyMT mouse model.
McDonald SJ; Cranford TL; VanderVeen BN; Cardaci TD; Velázquez KT; Enos RT; Chatzistamou I; Fan D; Murphy EA
Physiol Genomics; 2022 Nov; 54(11):433-442. PubMed ID: 36121133
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered mice as experimental tools to dissect the critical events in breast cancer.
Menezes ME; Das SK; Emdad L; Windle JJ; Wang XY; Sarkar D; Fisher PB
Adv Cancer Res; 2014; 121():331-382. PubMed ID: 24889535
[TBL] [Abstract][Full Text] [Related]
11. Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor Progression.
Parigiani MA; Ketscher A; Timme S; Bronsert P; Schlimpert M; Kammerer B; Jacquel A; Chaintreuil P; Reinheckel T
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707827
[No Abstract] [Full Text] [Related]
12. SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancer.
Clark-Knowles KV; Dewar-Darch D; Jardine KE; McBurney MW
PLoS One; 2013; 8(11):e82106. PubMed ID: 24278473
[TBL] [Abstract][Full Text] [Related]
13. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.
Bissell MJ; Kenny PA; Radisky DC
Cold Spring Harb Symp Quant Biol; 2005; 70():343-56. PubMed ID: 16869771
[TBL] [Abstract][Full Text] [Related]
14. Isolating Primary Tumor Cells from the MMTV-PyMT Mouse Model and Their Use in Developing an Orthotopic Mouse Model of Breast Cancer.
Kozak A; Vasiljeva O; Mikhaylov G
Methods Mol Biol; 2024; 2773():59-65. PubMed ID: 38236536
[TBL] [Abstract][Full Text] [Related]
15. Effect of 2-methoxyestradiol on mammary tumor initiation and progression.
Peta KT; Durandt C; van Heerden MB; Joubert AM; Pepper MS; Ambele MA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2068. PubMed ID: 38600057
[TBL] [Abstract][Full Text] [Related]
16. Author Correction: Microfluidics delivery of DARPP-32 into HeLa cells maintains viability for in-cell NMR spectroscopy.
Sciolino N; Liu A; Breindel L; Burz DS; Sulchek T; Shekhtman A
Commun Biol; 2022 Jul; 5(1):673. PubMed ID: 35798845
[No Abstract] [Full Text] [Related]
17. DARPP-32: from neurotransmission to cancer.
Belkhiri A; Zhu S; El-Rifai W
Oncotarget; 2016 Apr; 7(14):17631-40. PubMed ID: 26872373
[TBL] [Abstract][Full Text] [Related]
18. t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib.
Christenson JL; Denny EC; Kane SE
Oncotarget; 2015 Oct; 6(32):33134-45. PubMed ID: 26430732
[TBL] [Abstract][Full Text] [Related]
19. t-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells.
Lenz G; Hamilton A; Geng S; Hong T; Kalkum M; Momand J; Kane SE; Huss JM
Clin Cancer Res; 2018 Mar; 24(5):1216-1226. PubMed ID: 29180608
[No Abstract] [Full Text] [Related]
20. Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks.
Avanes A; Lenz G; Momand J
Biochem Pharmacol; 2019 Feb; 160():71-79. PubMed ID: 30552871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
